Ruth Moreno and Miriam Casiraghi
CNP, CRN, CTO Sidra Medicine, Qatar
Posters & Accepted Abstracts: Arch Med
Statement: Sidra Medicine, based in Doha, Qatar is the newest academic hospital in the country envisioned to be a beacon of learning, discovery and exceptional care. It’s been created under the umbrella of Qatar Foundation.
Sidra is a state-of-the-art facility committed to providing women and children in Qatar with world-class tertiary healthcare services, paired with dynamic research and education environment by collaborating with its academic partners, and leading national and international research institutions. The Research Branch of Sidra is an international biomedical research institute created in 2015, aiming to deliver translational research to the population of Qatar and the world to enhance scientific breakthroughs and personalized medicine care.
Methodology: The recently introduced Research Governance Framework presents a structured, planned and permanent approach that supports the Vision and Mission of Sidra Medicine. It describes how research operations are directed, led and controlled. Furthermore, it includes systems, principles and processes that are directed towards ensuring quality and integrity in research operations and governing the safety of all clinical research.
Findings: To support research at Sidra, a newly established Clinical Trials Office has been created within the Research Branch. CTO serves as the focal point and centralized coordinating office for all clinical research to be conducted in the hospital. The mission is to facilitate the design and conduct of ethical and scientifically valid clinical research with core administrative and operational services.
Conclusion: Sidra Medicine is striving to get the Joint Commission International accreditation as a Hospital within 2019. It is pursuing JCI accreditation as an Academic Medical Center which requires compliance with the JCI Human Subjects Research Program. The HRP purpose is to ensure that research is conducted in accordance to the protection of the rights, welfare and dignity, by providing support, guidance, and education.
Recent Publications
1. Brioude F, Kalish JM, Mussa A, Foster AC, Bliek J, Ferrero GB, Boonen SE, Cole T, Baker R, Bertoletti M, Cocchi G, Coze C, De Pellegrin M, Hussain K, Ibrahim A, Kilby MD, Krajewska-Walasek M, Kratz CP, Ladusans EJ, Lapunzina P, Le Bouc Y, Maas SM, Macdonald F, Õunap K, Peruzzi L, Rossignol S, Russo S, Shipster C, Skorka A, Tatton-Brown K, Tenorio J, Tortora C, Grønskov K, Netchine I, Hennekam RC, Prawitt D, Tumer Z, Eggermann T, Mackay DJG, Riccio A, Maher ER. (2018). Expert consensus document: Clinical and molecular diagnosis, screening and management of Beckwith–Wiedemann syndrome: an international consensus statement. Nature Reviews Endocrinology, 14(4), 229–249. doi:10.1038/nrendo.2017.166.
2. Maccalli, C., Rasul, K. I., Elawad, M., & Ferrone, S. (2018). The role of cancer stem cells in the modulation of anti-tumor immune responses”. Seminars in Cancer Biology. doi:10.1016/j.semcancer.2018.09.006.
3. Kenny D, Rhodes JF, Fleming GA, Kar S, Zahn EM, Vincent J, Shirali GS, Gorelick J, Fogel MA, Fahey JT, Kim DW, Babaliaros VC, Armstrong AK, Hijazi ZM. (2018). 3-Year Outcomes of the Edwards SAPIEN Transcatheter Heart Valve for Conduit Failure in the Pulmonary Position From the COMPASSION Multicenter Clinical Trial. JACC: Cardiovascular Interventions, 11(19), 1920–1929. doi:10.1016/j. jcin.2018.06.001.
4. Alkhouli, M., Hijazi, Z. M., Holmes, D. R., Rihal, C. S., & Wiegers, S. E. (2018). Intracardiac Echocardiography in Structural Heart Disease Interventions. JACC: Cardiovascular Interventions, 11(21), 2133–2147. doi:10.1016/j.jcin.2018.06.056
5. Angelova M, Mlecnik B, Vasaturo A, Bindea G, Fredriksen T, Lafontaine L, Buttard B, Morgand E, Bruni D, Jouret-Mourin A, Hubert C, Kartheuser A, Humblet Y, Ceccarelli M, Syed N, Marincola FM, Bedognetti D, Van den Eynde M, Galon J. (2018). Evolution of Metastases in Space and Time under Immune Selection. Cell. doi:10.1016/j.cell.2018.09.018.
Ruth Moreno, has Bachelor Degree in Chemistry. She has her expertise in clinical trials for more than 10 years in pharmaceutical Company. Now, at Sidra she works as a Clinical protocol manager, to give all the support needed in Clinical Research.
Miriam Casiraghi, is a Clinical Nurse Practitioner with 12 years of experience followed by other 12 years as Research Clinical Nurse in Gene Therapy Trials.
As a core, CTO can guide and support investigators through the journey of conducting a clinical research, by providing necessary background, guidelines and regulations.
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 
